Shionogi presents real-world data on cefiderocol's effectiveness against tough-to-treat gram-negative infections, while GSK releases promising phase 3 data for tebipenem HBr.
In 2025 there have been 25 H9N2 cases reported from mainland China.
Immunocompromised adults and children should receive an age-appropriate COVID-19 vaccine dose as soon as possible, the organization says.
Infectious disease information from CIDRAP.
Discussion & analysis on the latest infectious disease developments by Dr. Osterholm and Chris Dall.
CIDRAP staff are frequently featured on other news sites. Please see our opinion pieces, commentaries, and other features.
Data on novel vaccine candidates in clinical or late preclinical development.
CIDRAP and Osterholm Update podcast merchandise is available for purchase. Order t-shirts, mugs, socks, buttons, stickers, and more!
The Influenza Vaccines R&D Roadmap Initative
The Influenza Vaccines Roadmap provides a much-needed framework for organizing the efforts of existing influenza researchers while identifying a wide range of opportunities that will encourage new investigators to join the work.
"This is not business as usual anymore, but it doesn't mean that we have to sit back and take it."
Study on masks vs N95 respirators for health workers spurs concerns
The findings suggest medical masks may offer similar protection as respirators against COVID-19, but experts say hold on.
